Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07685769 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India

Name: A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India — clinical trial record (NCT07685769)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorPfizer

Started2026-07-24

View on ClinicalTrials.gov ↗

This is a multicenter, single-arm, open-label Phase 4 study evaluating the safety and tolerability of rimegepant 75 mg orally disintegrating tablet (ODT) for the acute treatment of migraine (with or without aura) in adult patients in India who have had an insufficient response, intolerance, or contraindication to triptans. It will enroll approximately 60 participants.

Amendment history 1 change detected by DataLookout

2026-08-22

Recruitment opened

Trial Details

NCT Number	NCT07685769
Lead Sponsor	Pfizer
Conditions	Acute Treatment of Migraine
Enrollment	60 participants
Start Date	2026-07-24
Primary Completion	2028-01-04 (estimated)
Study Completion	2028-01-04 (estimated)
Updated on ClinicalTrials.gov	2026-08-21